Gilead Sciences’ Post

View organization page for Gilead Sciences, graphic

618,131 followers

We're proud to have contributed to this milestone announced by the World Health Organization - marking the elimination of visceral leishmaniasis (VL) as a public health problem in Bangladesh, the first country globally to eliminate this life-threatening, neglected tropical disease.

View profile for Professor Jérôme SALOMON, graphic
Professor Jérôme SALOMON Professor Jérôme SALOMON is an Influencer

WHO Assistant Director General UCN: UHC Communicable Noncommunicable diseases Mental Health, Global Fund UNAIDS UNITAID Board member/ Sous Directeur General OMS, CSU Maladies transmissibles et chroniques, santé mentale

The World Health Organization today announced elimination of visceral #leishmaniasis as a #publichealth problem by #Bangladesh, interruption of #leprosy transmission by #Maldives and elimination of #rubella by DPR #Korea Bangladesh has become the 1st country globally to be validated for elimination of visceral leishmaniasis or #kalaazar, a life-threatening neglected tropical disease #NTDs. The country achieved the elimination target of less than 1 case/10,000 population at the sub-district level in 2017 and has sustained it to date despite disruptions caused by the #COVID19 #pandemic Maldives is the 1st country to verify interruption of transmission of leprosy, having achieved the milestone of no #child case detection for more than 5 consecutive years. In 2019 Maldives published a Framework for Zero leprosy with clear milestones to reach leprosy elimination by 2030. An independent assessment team by WHO highlighted high political will and #community motivation, along with strong health systems and minimal evidence of #stigma and #discrimination towards persons affected by leprosy, as the key factors for #Maldives’ success The WHO SEARO Commission for #Measles and Rubella Elimination, based on the evidence provided by the National Verification Committee of DPR Korea, concluded that #endemic rubella #virus has been eliminated from the country. DPR Korea introduced measles-rubella #vaccine in childhood #immunization programme in 2019 after successfully carrying out a wide age range immunization campaign targeting 9 months to 15 years old #children and 16 to 18 years old #women with measles and rubella vaccines. Through this mass immunization activity, achieving more than 99.8% coverage in almost 6 M target population, the country rapidly built substantial population immunity for rubella #Neglected #tropical #diseases like lymphatic filariasis, visceral leishmaniasis and leprosy, along with the threat to children and young people posed by rubella, require continued national leadership, commitment and collaborative action by countries and health partners worldwide said WHO DG Tedros Adhanom Ghebreyesus Elimination of NTDs and childhood killer and debilitating diseases measles and rubella have been among the flagship priority programmes of the Region focusing on #trachoma, lymphatic #filariasis, visceral leishmaniasis #kalaazar, #yaws and leprosy. The Region has witnessed 95% decline in new cases of kala azar in the last 10 years. The Special Programme for #Research and #Training in Tropical Diseases and WHO, the Government of Bangladesh and partners such as the Government of the United Kingdom, Gilead Sciences, the Bill & Melinda Gates Foundation, Drugs for Neglected Diseases initiative - DNDi and the INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH BANGLADESH supported research and development of new #diagnostic #tools and effective #treatments, that helped accelerate the #elimination of kala-azar in Bangladesh Dr Ibrahima Socé Fall

  • No alternative text description for this image
Michel Joly

Vice-President of Gilead Global Patient Solutions (GPS)

6mo

Visceral leishmaniasis is a life-threatening condition affecting communities in some of the world’s poorest areas. Kudos to all people achieving this. One step closer to ending visceral leishmaniasis in endemic countries.

Megan Blanton, RN, BSN

Senior Pharmacovigilance Specialist | Enhancing Drug Safety and Compliance in the Pharmaceutical Industry 🌐

6mo

What a fantastic outcome of such hard work! To think of how many lives have been touched by this is heartwarming. Congratulations!

Like
Reply
Moshiul Islam Pavel

General Manager at ZAS Corporation Ltd

6mo

Thanks to Gilead Sciences for your remarkable contribution for Bangladesh

Chinmayi Vembar, SHRM-CP

Director Human Resources at Gilead Sciences

6mo

Feel proud to be sharing this!

Like
Reply
Dr. Harald Nusser

Healthcare Executive / Board Member / Thought Leader / Intrapreneur / ESG

6mo

Aida Meskel, M.P.H. Bahar Turkoglu James Armstrong Dennis Israelski Gijs Crone

Like
Reply
JoAnn Parsi

Senior Clinical Research Associate | GCP, Regulatory Submissions

6mo

Funtastics news!

Like
Reply
Chandan Shah

Associate Scientist in Neuroscience at Regeneron

6mo
Like
Reply
David H.

Healthcare Administration Professional

6mo

Incredible!!! 🙌

Like
Reply

Great news!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics